Restoration of daunomycin retention in multidrug-resistant P388 cells by submicromolar concentrations of SDZ PSC 833, a nonimmunosuppressive cyclosporin derivative.
about
The reversal of antineoplastic drug resistance in cancer cells by β-elemenePathways and progress in improving drug delivery through the intestinal mucosa and blood-brain barriersMerck Frosst Award Lecture 1998. Molecular dissection of the human multidrug resistance P-glycoprotein.Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins.P glycoprotein in human immunodeficiency virus type 1 infection and therapy.Effect of cyclosporin A and analogues on cytosolic calcium and vasoconstriction: possible lack of relationship to immunosuppressive activity.SDZ 280-446, a novel semi-synthetic cyclopeptolide: in vitro and in vivo circumvention of the P-glycoprotein-mediated tumour cell multidrug resistance.Distribution and activity of doxorubicin combined with SDZ PSC 833 in mice with P388 and P388/DOX leukaemiaIsolation and characterization of an IGROV-1 human ovarian cancer cell line made resistant to Ecteinascidin-743 (ET-743).A functional model for feline P-glycoprotein.Reversal of multidrug resistance by co-delivery of tariquidar (XR9576) and paclitaxel using long-circulating liposomes.P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells.A multidrug-resistance protein (MRP)-like transmembrane pump is highly expressed by resting murine T helper (Th) 2, but not Th1 cells, and is induced to equal expression levels in Th1 and Th2 cells after antigenic stimulation in vivo.The genetic basis of resistance to cancer chemotherapy.Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.Inhibitory effects of a cyclosporin derivative, SDZ PSC 833, on transport of doxorubicin and vinblastine via human P-glycoprotein.Mechanisms of hepatic transport of cyclosporin A: an explanation for its cholestatic action?Pharmacokinetics of PSC 833 (valspodar) in its Cremophor EL formulation in rat.A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lung cancer cells.Intracellular levels of two cyclosporin derivatives valspodar (PSC 833) and cyclosporin a closely associated with multidrug resistance-modulating activity in sublines of human colorectal adenocarcinoma HCT-15.Modulation of the typical multidrug resistance phenotype by targeting the MED-1 region of human MDR1 promoter.Drug binding to P-glycoprotein is inhibited in normal tissues following SDZ-PSC 833 treatment.Valspodar: current status and perspectives.Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo.Cyclosporin A enhances susceptibility of multi-drug resistant human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes.Recent developments in overcoming tumour cell multi-drug resistanceABCB- and ABCC-type transporters confer multixenobiotic resistance and form an environment-tissue barrier in bivalve gills
P2860
Q26787004-8D91F271-89DB-4157-BCC8-058C8D7EBC12Q26852773-813095E5-F09B-4B1C-8E27-C5D227CC7451Q33699333-62A3A101-6374-4BF6-A3FF-D36BF58AADF7Q34416847-7CF522DF-2B43-4FF4-9317-F2828812FAF8Q35718765-0A669704-E4E9-402D-BCE6-E0C04411707BQ35873547-7A89DC97-1E5E-4625-BC28-AEBB0EA20FA4Q35992919-606A3D8E-73A9-4C17-A9FE-EDF7EEDE9FA9Q36134341-0251A0B5-9E04-4048-A66A-7A77FF9E1621Q36641741-BEC4F474-927D-479D-A456-3AF55EF52C12Q38851357-A60B467B-E543-465B-A9F6-53254CC0E187Q39518456-6D6D5910-61C1-4C77-A47E-8A8D79E721A9Q39552900-C6BBC407-8893-4C4E-AAD0-4142BD903D08Q39798616-6729D983-EB12-478A-9F14-B57613A05FBBQ40458699-0C8D4B46-55F7-4CD5-B6FC-0EE9584F4990Q40600988-3B92DEE2-3E6E-4091-9CB0-E59DC895DA10Q40978951-29944621-2DF0-44CE-8ADC-46C061468FDDQ41564063-10B203E2-2FB7-4013-ABA6-F376E655ECA0Q43244972-71C920A9-F597-4C6A-B495-0A7B260C1D78Q43688392-A650DC7B-F554-4253-88D1-8119AFE18FA5Q43777030-44CBE030-6332-479D-9D27-3252B8C5CCEDQ45869623-867B76C6-4CD3-4BA1-A043-B8A83E9F63CEQ48017742-8BFB1917-F297-4B3B-B7B0-8D831050D22CQ48826637-776A801E-A447-4677-B301-53A72745B197Q54186927-FB2A24F4-549A-4178-84AA-4CF436FCE4FBQ55282642-0AF65650-EF1D-42E6-8697-D173715B5436Q56992416-5436DAD6-4B17-4647-ADE2-8100FE3A802DQ57003929-1A4A257F-2483-4151-921B-FB87AFD40340
P2860
Restoration of daunomycin retention in multidrug-resistant P388 cells by submicromolar concentrations of SDZ PSC 833, a nonimmunosuppressive cyclosporin derivative.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Restoration of daunomycin rete ...... essive cyclosporin derivative.
@en
type
label
Restoration of daunomycin rete ...... essive cyclosporin derivative.
@en
prefLabel
Restoration of daunomycin rete ...... essive cyclosporin derivative.
@en
P2093
P1476
Restoration of daunomycin rete ...... essive cyclosporin derivative.
@en
P2093
A Pourtier-Manzanedo
P356
10.1016/0014-4827(91)90452-Z
P407
P577
1991-09-01T00:00:00Z